EVERY Company Secures $55 Million in Funding
The EVERY Company has secured $55 million in a Series D funding round to scale up production of animal-free egg proteins.
This funding will support the company's expansion into the US market, led by McWin Capital Partners, with participation from investors including Main Sequence, Bloom8, and Minerva Foods.
EVERY is proving that biomanufacturing has the potential to transform the food industry
Precision-Fermented Egg Proteins
The company's fermentation-based technology offers alternatives to traditional egg proteins, including OvoPro™ and OvoBoost™, designed to replace conventional eggs in products such as baked goods, beverages, and protein supplements.
- OvoPro™: a substitute for egg whites
- OvoBoost™: a neutral protein for various food and beverage applications
Author's summary: EVERY Company secures funding to expand production.
More News
- Style, Swagger, And Star Power: Rihanna, Ciara, Olandria, Angel Reese And More Shine At The 2025 CFDA Fashion Awards
- Inside Selling Sunset Star Bre Tiesi's Lawsuit
- Patriots Avoided a Big Mistake After Jakobi Meyers Trade News
- High wind Warning Issued for Our Area - Sonoma Valley Sun
- Toronto Tempo Wins the Sandy Brondello Sweepstakes
- "Moore keeps redistricting push alive in Maryland amid national map fights" #ELB
- M084-EEUU VOTACION ZHORAN MAMDANI
- Is Avocado Oil Liquid Gold for Cholesterol? - BlackDoctor.org - Where Wellness & Culture Connect
- Canada's immigration system is lost in the bushes
- What Cajuns Really Eat for Thanksgiving